Clinical Trial Update: Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium [Phase 1]

View source ↗

Summary

This entry reports the completion of a Phase 1 safety and feasibility study of the dapivirine vaginal ring (TMC120) for HIV prevention conducted in Belgium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dapivirine vaginal ring (dapivirine)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: HIV Infections | Phase 1 | Status: COMPLETED